Can a tiny sensor protect newborns from dangerous low blood sugar?
NCT ID NCT07462793
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether using a continuous glucose monitor (CGM) can help find and manage low blood sugar in newborns whose mothers had insulin-treated gestational diabetes. About 120 babies will be monitored for the first 72 hours after birth. The goal is to see if CGM catches more low blood sugar episodes than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Mother and Child
Warsaw, 01-211, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a higher steroid dose help preterm babies breathe easier?
- Could a tiny sensor spare newborns dozens of needle sticks?
- Hidden toll of gestational diabetes: study probes emotional and social impact
- Community-Driven strategies aim to end intergenerational type 2 diabetes in indigenous children
- Could a simple supplement help manage gestational diabetes?
- Could a daily glass of kefir during pregnancy ward off gestational diabetes?